[Cerebral blood flow measurements in patients with comorbid hypertension and depression using 3D arterial spin

Y Liu1, X Z Zeng1, Z Wang1

  • 1Department of Radiology, Peking University Third Hospital, Beijing 100191, China.

Insights

Patients with comorbid hypertension and depression show reduced cerebral blood flow (CBF) in specific brain regions. This suggests hypertension may worsen cerebral hypoperfusion in individuals with co-occurring depression.

Area of Science:

  • Neuroimaging
  • Cardiovascular Science
  • Psychiatry

Background:

  • Depression and hypertension are prevalent conditions often co-occurring.
  • Cerebral blood flow (CBF) alterations may underlie cognitive deficits in these conditions.
  • 3D pseudocontinuous arterial spin labeling (3D pcASL) is a non-invasive MRI technique for CBF measurement.

Purpose of the Study:

  • To evaluate CBF in patients with comorbid hypertension and depression using 3D pcASL.
  • To compare CBF differences between depression, hypertension, comorbid hypertension, and healthy controls.
  • To investigate the correlation between CBF and depression severity.

Main Methods:

  • Recruited four groups: depression (n=16), hypertension (n=16), comorbid hypertension and depression (n=16), and healthy controls (n=16).
  • Acquired 3D pcASL MRI data on a GE 3.0T scanner.
  • Analyzed CBF maps using Statistical Parametric Mapping (SPM8) and compared groups using ANOVA.

Main Results:

  • Comorbid hypertension in depression showed significantly lower CBF in frontal, parietal, caudate nucleus, and insula regions compared to controls.
  • No significant CBF differences were found between hypertension and control groups.
  • Patients with comorbid hypertension and depression exhibited lower frontal lobe CBF compared to those with depression alone.

Conclusions:

  • Regional hypoperfusion was observed in patients with comorbid hypertension and depression, particularly in frontal regions.
  • Hypertension may synergistically exacerbate cerebral hypoperfusion in comorbid depression.
  • No significant correlation was found between CBF values and depression severity (HAMD-17 scores).
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.0K
Blood Flow01:29

Blood Flow

Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
75.7K
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
587
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
7.6K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
452